| Autor: |
Furitsu Shimada, Hiroyoshi Endo, Ayako Takamori, Takuya Matsunaga, Shun Fujimoto, Shimpei Shirai, Toshihiko Kakiuchi, Takashi Akutagawa, Yasuhisa Sakata, Koichi Node, Kohei Yamanouchi, Shotaro Nakamura, Kazuma Fujimoto, Motohiro Esaki |
| Jazyk: |
angličtina |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
JGH Open, Vol 5, Iss 11, Pp 1284-1288 (2021) |
| Druh dokumentu: |
article |
| ISSN: |
2397-9070 |
| DOI: |
10.1002/jgh3.12666 |
| Popis: |
Abstract Background and Aim The aim of the present study was to examine the lifestyle‐ and comorbidity‐related determinant factors of the prescription of proton pump inhibitors (PPIs) for patients in whom Helicobacter pylori has been eradicated, and to evaluate the relationship between PPI prescription and the severity of endoscopic esophagitis. Methods This retrospective study included patients who underwent H. pylori eradication from May 2012 to September 2016 at Saiseikai Karatsu Hospital. All patients received upper gastrointestinal endoscopy before H. pylori eradication. Patients with open peptic ulcers and/or malignant diseases were excluded, and a final total of 389 patients were evaluated. Medical records were reviewed to determine the prescription of PPIs after H. pylori eradication, lifestyle‐related factors, and comorbidities. Lifestyle‐related factors were confirmed by a questionnaire. Results PPIs were administered to 124 of 389 patients (31.9%). The only lifestyle‐related risk factor for the prescription of PPIs after H. pylori eradication was older age (P |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
Plný text